DE60309731D1 - Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern - Google Patents
Injizierbare pharmazeutische suspension in einer phiole mit zwei kammernInfo
- Publication number
- DE60309731D1 DE60309731D1 DE60309731T DE60309731T DE60309731D1 DE 60309731 D1 DE60309731 D1 DE 60309731D1 DE 60309731 T DE60309731 T DE 60309731T DE 60309731 T DE60309731 T DE 60309731T DE 60309731 D1 DE60309731 D1 DE 60309731D1
- Authority
- DE
- Germany
- Prior art keywords
- formulation
- chamber
- gaseous medium
- injectable pharmaceutical
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/02—Internal fittings
- B65D25/04—Partitions
- B65D25/08—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents
- B65D25/082—Partitions with provisions for removing or destroying, e.g. to facilitate mixing of contents the partition being in the form of a plug or the like which is removed by increasing or decreasing the pressure within the container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2041—Separating means having removable plugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40498802P | 2002-08-21 | 2002-08-21 | |
US404988P | 2002-08-21 | ||
PCT/US2003/026005 WO2004018312A1 (en) | 2002-08-21 | 2003-08-20 | Injectable pharmaceutical suspension in a two-chamber vial |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60309731D1 true DE60309731D1 (de) | 2006-12-28 |
DE60309731T2 DE60309731T2 (de) | 2007-06-28 |
Family
ID=31946796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003609731 Expired - Lifetime DE60309731T2 (de) | 2002-08-21 | 2003-08-20 | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern |
Country Status (10)
Country | Link |
---|---|
US (1) | US7387623B2 (de) |
EP (1) | EP1545994B1 (de) |
JP (1) | JP4416653B2 (de) |
AT (1) | ATE345277T1 (de) |
AU (1) | AU2003265511A1 (de) |
CA (1) | CA2494825C (de) |
DE (1) | DE60309731T2 (de) |
ES (1) | ES2273078T3 (de) |
NO (1) | NO328187B1 (de) |
WO (1) | WO2004018312A1 (de) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7275640B2 (en) * | 2004-02-05 | 2007-10-02 | Boston Scientific Scimed, Inc. | Packaging for imparting anti-microbial properties to a medical device |
EP1746883A4 (de) * | 2004-05-13 | 2009-07-08 | Anthony R Talamonti | Medizinisches behandlungskit und verfahren für seinen einsatz |
GB2414405B (en) * | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414406B (en) | 2004-05-28 | 2009-03-18 | Cilag Ag Int | Injection device |
GB2414404B (en) | 2004-05-28 | 2009-06-03 | Cilag Ag Int | Injection device |
GB2414401B (en) | 2004-05-28 | 2009-06-17 | Cilag Ag Int | Injection device |
GB2414400B (en) * | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414403B (en) * | 2004-05-28 | 2009-01-07 | Cilag Ag Int | Injection device |
GB2414409B (en) * | 2004-05-28 | 2009-11-18 | Cilag Ag Int | Injection device |
GB2414399B (en) * | 2004-05-28 | 2008-12-31 | Cilag Ag Int | Injection device |
GB2414775B (en) * | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
GB2414402B (en) * | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
BRPI0518790A2 (pt) * | 2004-12-02 | 2008-12-09 | Wyeth Corp | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete |
EP1853234A2 (de) * | 2005-02-15 | 2007-11-14 | Elan Pharma International Limited | Aerosol und injizierbare formulierungen aus benzodiazepin in form von nanoteilchen |
GB2424838B (en) * | 2005-04-06 | 2011-02-23 | Cilag Ag Int | Injection device (adaptable drive) |
GB2424837B (en) * | 2005-04-06 | 2010-10-06 | Cilag Ag Int | Injection device |
GB2424836B (en) * | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
GB2425062B (en) * | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
GB2424835B (en) * | 2005-04-06 | 2010-06-09 | Cilag Ag Int | Injection device (modified trigger) |
GB2427826B (en) | 2005-04-06 | 2010-08-25 | Cilag Ag Int | Injection device comprising a locking mechanism associated with integrally formed biasing means |
PL1759729T3 (pl) | 2005-08-30 | 2010-09-30 | Cilag Gmbh Int | Zestaw igły do wstępnie napełnionego systemu strzykawki |
US20070074980A1 (en) * | 2005-09-02 | 2007-04-05 | Bankoski Brian R | Implant rehydration packages and methods of use |
US20110098656A1 (en) | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
JP4897879B2 (ja) | 2006-05-25 | 2012-03-14 | バイエル・ヘルスケア・エルエルシー | 再構成デバイス |
GB2438591B (en) * | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
GB2438590B (en) | 2006-06-01 | 2011-02-09 | Cilag Gmbh Int | Injection device |
US20080077116A1 (en) * | 2006-09-12 | 2008-03-27 | Rosemary Dailey | Container for intravenous fluids |
ES2399629T3 (es) * | 2006-09-29 | 2013-04-02 | Infa S.A. | Sistema de acondicionamiento para composiciones farmacéuticas y kit para administración intravenosa |
CA2697160A1 (en) * | 2007-08-21 | 2009-02-26 | Harbor Biosciences, Inc. | Stabilized therapeutic compositions and formulations |
US20090084804A1 (en) * | 2007-10-01 | 2009-04-02 | Hospira, Inc. | Snap-over port cap |
US8091727B2 (en) * | 2007-11-08 | 2012-01-10 | Hospira, Inc. | Snap-over clamshell protective port cap |
CN101932327A (zh) | 2007-12-19 | 2010-12-29 | 詹森药业有限公司 | 与长效注射用帕潘立酮酯相关的给药方案 |
GB2461086B (en) * | 2008-06-19 | 2012-12-05 | Cilag Gmbh Int | Injection device |
GB2461085B (en) | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
GB2461084B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Fluid transfer assembly |
GB2461087B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
GB2461089B (en) * | 2008-06-19 | 2012-09-19 | Cilag Gmbh Int | Injection device |
GB2461088B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
TW201103590A (en) * | 2009-06-02 | 2011-02-01 | Sanofi Aventis Deutschland | Medicated module with integral flow distribution system |
TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前-乳劑調配物及其製造與使用之方法 |
CN102970990A (zh) | 2010-05-03 | 2013-03-13 | 帝国制药美国公司 | 非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法 |
BR112013004757A2 (pt) * | 2010-08-27 | 2016-08-02 | Sanofi Aventis Deutschland | pacote primário para uso em módulo medicamentoso, módulo medicamentoso, método para dispensar microdose de medicamento e sistema de distribuição de fluxo |
US20130115253A1 (en) * | 2011-11-07 | 2013-05-09 | Mahendra R. Patel | Sustained Release Suspension Preparation For Dextromethorphan |
US20140377343A1 (en) * | 2011-12-23 | 2014-12-25 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Formulations of flurbiprofen and diacerein |
WO2013095318A2 (en) * | 2011-12-23 | 2013-06-27 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally-disintegrating formulations of flurbiprofen |
EP2793855B1 (de) * | 2011-12-23 | 2015-12-16 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Flurbiprofen-formulierungen |
US20150004229A1 (en) * | 2011-12-27 | 2015-01-01 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Combined pharmaceutical formulation containing diacerein |
EA201491039A1 (ru) * | 2011-12-27 | 2015-02-27 | Сановел Илач Санайи Ве Тиджарет Аноним Ширкети | Комбинации диацереина и нестероидных противовоспалительных лекарственных средств |
EP2797681B1 (de) * | 2011-12-29 | 2017-02-01 | Omrix Biopharmaceuticals Ltd. | Verfahren und vorrichtung zur schnellen auflösung von festen proteinzusammensetzung |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
WO2014145767A1 (en) * | 2013-03-15 | 2014-09-18 | Lannett Company, Inc. | Multi-chamber anesthetic delivery system |
GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
GB201313368D0 (en) * | 2013-07-26 | 2013-09-11 | Xstalbio Ltd | Novel Reconstitution devices |
US9216175B2 (en) * | 2013-09-10 | 2015-12-22 | Insys Pharma, Inc. | Sublingual buprenorphine spray |
US10722510B2 (en) | 2014-07-08 | 2020-07-28 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
US10617686B2 (en) | 2014-07-08 | 2020-04-14 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
EP3177146A4 (de) | 2014-07-08 | 2018-01-03 | Insys Pharma, Inc. | Sublinguale naloxon spray |
WO2016036588A1 (en) * | 2014-09-03 | 2016-03-10 | Merck Sharp & Dohme Corp. | Pharmaceutical suspensions containing etoricoxib |
US20160346219A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
US11229702B1 (en) | 2015-10-28 | 2022-01-25 | Coherus Biosciences, Inc. | High concentration formulations of adalimumab |
US11135154B2 (en) | 2016-03-02 | 2021-10-05 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
US11071782B2 (en) * | 2016-04-20 | 2021-07-27 | Coherus Biosciences, Inc. | Method of filling a container with no headspace |
US20200281939A1 (en) * | 2017-09-07 | 2020-09-10 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
EP3678637A1 (de) * | 2017-09-07 | 2020-07-15 | Teva Pharmaceutical Industries Ltd. | Injizierbare medroxyprogesteronacetatzusammensetzungen und verfahren zur verwendung |
MX2021000837A (es) * | 2018-07-27 | 2021-03-25 | Hoffmann La Roche | Metodo para llenar recipientes con al menos un producto farmaceutico desgasificado y dispositivo de llenado para productos farmaceuticos. |
WO2020049521A1 (en) | 2018-09-07 | 2020-03-12 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
MX2018011142A (es) | 2018-09-13 | 2019-10-10 | Federico Amezcua Amezcua | Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona. |
MX2021004356A (es) * | 2018-10-18 | 2021-05-31 | Merck Sharp & Dohme Llc | Formulaciones de anticuerpos anti-rsv y metodos de uso de las mismas. |
US20220287914A1 (en) * | 2021-03-10 | 2022-09-15 | Carol L. Ovans | Cone-Shaped Bottle Insert |
WO2024089634A1 (en) | 2022-10-27 | 2024-05-02 | Pfizer Inc. | Immunogenic compositions against influenza and rsv |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3087638A (en) * | 1961-12-15 | 1963-04-30 | Abbott Lab | Closure assembly |
US3464414A (en) | 1963-07-31 | 1969-09-02 | Upjohn Co | Mixing vial construction |
US3457348A (en) | 1966-06-27 | 1969-07-22 | American Cyanamid Co | Stable syringeable suspensions of parenteral drugs in complex floc form |
US4089432A (en) * | 1977-05-06 | 1978-05-16 | The Upjohn Company | Vial and closure |
NL191048C (nl) * | 1977-09-14 | 1995-01-02 | Pemberton Sintermatic | Inrichting voor het via coagulatie van proteine vervaardigen van ten minste een samenhangend buitenoppervlak van een proteine bevattend voedselprodukt. |
US4258845A (en) | 1979-11-20 | 1981-03-31 | The Upjohn Company | Activator closure for two-compartment vial |
US4614267A (en) | 1983-02-28 | 1986-09-30 | Abbott Laboratories | Dual compartmented container |
US4871354A (en) | 1986-07-24 | 1989-10-03 | The West Company | Wet-dry bag with lyphozation vial |
US5336180A (en) | 1990-04-24 | 1994-08-09 | Science Incorporated | Closed drug delivery system |
SE9201246D0 (sv) * | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | Injection cartridge arrangement |
JPH05317383A (ja) | 1992-05-19 | 1993-12-03 | Nissho Corp | 薬剤容器との連通手段を備えた溶解液容器 |
US5385546A (en) | 1992-06-24 | 1995-01-31 | Science Incorporated | Mixing and delivering system |
US5335773A (en) | 1993-07-02 | 1994-08-09 | Habley Medical Technology Corporation | Multi-pharmaceutical storage, mixing and dispensing vial |
US5462526A (en) * | 1993-09-15 | 1995-10-31 | Mcgaw, Inc. | Flexible, sterile container and method of making and using same |
DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
EP1251742A4 (de) * | 1999-10-18 | 2004-10-06 | Dial Corp | Vorrichtung und verfahren zur herstellung von hüllenlosen würsten |
US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
WO2001087262A2 (en) | 2000-05-15 | 2001-11-22 | Pharmacia Italia S.P.A. | Stabilized steroidal suspension |
JP2004337318A (ja) * | 2003-05-14 | 2004-12-02 | Otsuka Pharmaceut Factory Inc | 医療用複室容器及びその製造方法 |
-
2003
- 2003-08-20 US US10/644,516 patent/US7387623B2/en active Active
- 2003-08-20 CA CA 2494825 patent/CA2494825C/en not_active Expired - Fee Related
- 2003-08-20 WO PCT/US2003/026005 patent/WO2004018312A1/en active IP Right Grant
- 2003-08-20 JP JP2004531095A patent/JP4416653B2/ja not_active Expired - Lifetime
- 2003-08-20 ES ES03793140T patent/ES2273078T3/es not_active Expired - Lifetime
- 2003-08-20 DE DE2003609731 patent/DE60309731T2/de not_active Expired - Lifetime
- 2003-08-20 EP EP03793140A patent/EP1545994B1/de not_active Expired - Lifetime
- 2003-08-20 AU AU2003265511A patent/AU2003265511A1/en not_active Abandoned
- 2003-08-20 AT AT03793140T patent/ATE345277T1/de not_active IP Right Cessation
-
2005
- 2005-03-16 NO NO20051372A patent/NO328187B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2494825C (en) | 2009-02-17 |
EP1545994B1 (de) | 2006-11-15 |
NO20051372L (no) | 2005-03-16 |
ES2273078T3 (es) | 2007-05-01 |
JP2005536285A (ja) | 2005-12-02 |
ATE345277T1 (de) | 2006-12-15 |
EP1545994A1 (de) | 2005-06-29 |
US7387623B2 (en) | 2008-06-17 |
NO328187B1 (no) | 2009-12-28 |
CA2494825A1 (en) | 2004-03-04 |
DE60309731T2 (de) | 2007-06-28 |
WO2004018312A1 (en) | 2004-03-04 |
US20040039366A1 (en) | 2004-02-26 |
JP4416653B2 (ja) | 2010-02-17 |
AU2003265511A1 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60309731D1 (de) | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern | |
EE05183B1 (et) | Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon | |
EA199900749A1 (ru) | Фармацевтическая композиция | |
EP1243524A3 (de) | Pharmazeutisches Kit fÜr sauerstoffempfindliche Medikamente | |
CL2010000816A1 (es) | Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06) | |
AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
AR036643A1 (es) | Compuestos organicos | |
EE200300054A (et) | Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid | |
DK0527801T3 (da) | Thiophensulfonamider, der er anvendelige som carboanhydraseinhibitorer | |
NO20022998D0 (no) | Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament | |
EA200401019A1 (ru) | Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества | |
GB2380675A (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
FR2679906B1 (fr) | Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
AR041588A1 (es) | Composicion farmaceutica estabilizada que comprende una sustancia activa amorfa | |
AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
AR037931A1 (es) | Metodo para granulacion humeda de azitromicina | |
PE20001326A1 (es) | Composicion farmaceutica que comprende cefuroxima-axetil, polimero y/o adsorbente | |
MXPA02012160A (es) | Composiciones medicinales las cuales contienen derivados de propenona. | |
PE20011223A1 (es) | Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico | |
ATE350021T1 (de) | Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir | |
CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
CO4830457A1 (es) | Preparados efervescentes | |
RS51578B (en) | SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN | |
ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
MEP16408A (en) | Combination of a taxane and a cyclin-dependent kinase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: PHARMACIA CORP., CHESTERFIELD, MO., US |
|
8364 | No opposition during term of opposition |